Philips sees profit hit from U.S. defibrillator blow

AMSTERDAM (Reuters) - Health technology company Philips is suspending the manufacture of some defibrillators in the United States and will make others under heightened scrutiny following criticisms from U.S. regulators, in a move it said would dent profits.

from Reuters: Health News http://reut.rs/2zeO7wY